Yeast vaccine shows promise in stopping Cancer's return

NCT ID NCT03552718

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a custom-made yeast vaccine designed to train the immune system to recognize and attack leftover cancer cells. Five adults with various cancers (like colorectal, breast, or lung) who had completed initial treatment received the vaccine. The goal was to see if it was safe and could help prevent the cancer from coming back.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chan Soon-Shiong Institute for Medicine

    El Segundo, California, 90245, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.